Brain-circuit treatment to help people with schizophrenia quit smoking
Part of Mental health clinical trials.
This study tests a circuitry-guided approach to help people with schizophrenia quit smoking. It may help reduce cravings and improve quitting, while also watching for safety issues.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re age 22 to 65 and can sign consent in writing
- You’ve smoked for at least 1 year, and you average 5+ cigarettes per day recently
- You have schizophrenia-spectrum disorder, and your screening scores are high enough to join
- You must be under care of a licensed doctor or mental health clinician
- You must allow study staff to contact your current/past providers and name 2 reliable contacts nearby
- You may not have had smoking-quit treatment, a clinical trial, or nicotine replacement in the last 4 weeks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new non-invasive brain stimulation technique to help long-term smokers quit. You'll receive a safe magnetic pulse to brain areas linked to cravings, and researchers track your progress.
This study tests if brain stimulation can improve how different brain regions communicate in people with schizophrenia. It may help improve thinking and daily function.
This study looks at how smoking affects brain networks in people with schizophrenia. It uses brain scans to see differences between smokers and non-smokers.
This trial tests whether combining brain stimulation (tDCS) with a smoking cessation medication (varenicline) helps people quit smoking. You would attend daily visits for two weeks.
This study tests whether combining the medication varenicline (Chantix) with a special brain stimulation treatment (TMS) can help people quit vaping or smoking nicotine. If you're motivated to quit and use nicotine daily, you may be able to join.
This study tests if a non-invasive brain stimulation technique can help reduce cravings for cannabis in people with schizophrenia. It aims to see if this approach can improve outcomes for those who use cannabis and have a psychotic disorder.
Hear when a new Smoking Cessation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.